192 related articles for article (PubMed ID: 18303046)
1. L- and S-endoglin differentially modulate TGFbeta1 signaling mediated by ALK1 and ALK5 in L6E9 myoblasts.
Velasco S; Alvarez-Muñoz P; Pericacho M; Dijke PT; Bernabéu C; López-Novoa JM; Rodríguez-Barbero A
J Cell Sci; 2008 Mar; 121(Pt 6):913-9. PubMed ID: 18303046
[TBL] [Abstract][Full Text] [Related]
2. Regulation of TGF-β receptor hetero-oligomerization and signaling by endoglin.
Pomeraniec L; Hector-Greene M; Ehrlich M; Blobe GC; Henis YI
Mol Biol Cell; 2015 Sep; 26(17):3117-27. PubMed ID: 26157163
[TBL] [Abstract][Full Text] [Related]
3. Endoglin differentially modulates antagonistic transforming growth factor-beta1 and BMP-7 signaling.
Scherner O; Meurer SK; Tihaa L; Gressner AM; Weiskirchen R
J Biol Chem; 2007 May; 282(19):13934-43. PubMed ID: 17376778
[TBL] [Abstract][Full Text] [Related]
4. Expression and functional analysis of endoglin in isolated liver cells and its involvement in fibrogenic Smad signalling.
Meurer SK; Tihaa L; Borkham-Kamphorst E; Weiskirchen R
Cell Signal; 2011 Apr; 23(4):683-99. PubMed ID: 21146604
[TBL] [Abstract][Full Text] [Related]
5. Activin Receptor-Like Kinase Receptors ALK5 and ALK1 Are Both Required for TGFβ-Induced Chondrogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells.
de Kroon LM; Narcisi R; Blaney Davidson EN; Cleary MA; van Beuningen HM; Koevoet WJ; van Osch GJ; van der Kraan PM
PLoS One; 2015; 10(12):e0146124. PubMed ID: 26720610
[TBL] [Abstract][Full Text] [Related]
6. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling.
Goumans MJ; Valdimarsdottir G; Itoh S; Lebrin F; Larsson J; Mummery C; Karlsson S; ten Dijke P
Mol Cell; 2003 Oct; 12(4):817-28. PubMed ID: 14580334
[TBL] [Abstract][Full Text] [Related]
7. NIM811 downregulates transforming growth factor‑β signal transduction in vivo and in vitro.
Chen J; Liu DG; Wang H; Wu XN; Cong M; You H; Jia JD
Mol Med Rep; 2016 Jan; 13(1):522-8. PubMed ID: 26573209
[TBL] [Abstract][Full Text] [Related]
8. TGFβ1-induced SMAD2/3 and SMAD1/5 phosphorylation are both ALK5-kinase-dependent in primary chondrocytes and mediated by TAK1 kinase activity.
van Caam A; Madej W; Garcia de Vinuesa A; Goumans MJ; Ten Dijke P; Blaney Davidson E; van der Kraan P
Arthritis Res Ther; 2017 May; 19(1):112. PubMed ID: 28569204
[TBL] [Abstract][Full Text] [Related]
9. Endoglin expression regulates basal and TGF-beta1-induced extracellular matrix synthesis in cultured L6E9 myoblasts.
Obreo J; Díez-Marques L; Lamas S; Düwell A; Eleno N; Bernabéu C; Pandiella A; López-Novoa JM; Rodríguez-Barbero A
Cell Physiol Biochem; 2004; 14(4-6):301-10. PubMed ID: 15319534
[TBL] [Abstract][Full Text] [Related]
10. ALK1 opposes ALK5/Smad3 signaling and expression of extracellular matrix components in human chondrocytes.
Finnson KW; Parker WL; ten Dijke P; Thorikay M; Philip A
J Bone Miner Res; 2008 Jun; 23(6):896-906. PubMed ID: 18333754
[TBL] [Abstract][Full Text] [Related]
11. Endoglin null endothelial cells proliferate faster and are more responsive to transforming growth factor beta1 with higher affinity receptors and an activated Alk1 pathway.
Pece-Barbara N; Vera S; Kathirkamathamby K; Liebner S; Di Guglielmo GM; Dejana E; Wrana JL; Letarte M
J Biol Chem; 2005 Jul; 280(30):27800-8. PubMed ID: 15923183
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of TGF-β-induced differentiation in human vascular smooth muscle cells.
Tang Y; Yang X; Friesel RE; Vary CP; Liaw L
J Vasc Res; 2011; 48(6):485-94. PubMed ID: 21832838
[TBL] [Abstract][Full Text] [Related]
13. Diabetes-relevant regulation of cultured blood outgrowth endothelial cells.
Wang S; Hirschberg R
Microvasc Res; 2009 Sep; 78(2):174-9. PubMed ID: 19539633
[TBL] [Abstract][Full Text] [Related]
14. Endoglin structure and function: Determinants of endoglin phosphorylation by transforming growth factor-beta receptors.
Koleva RI; Conley BA; Romero D; Riley KS; Marto JA; Lux A; Vary CP
J Biol Chem; 2006 Sep; 281(35):25110-23. PubMed ID: 16785228
[TBL] [Abstract][Full Text] [Related]
15. ALK1 regulates the internalization of endoglin and the type III TGF-β receptor.
Tazat K; Pomeraniec-Abudy L; Hector-Greene M; Szilágyi SS; Sharma S; Cai EM; Corona AL; Ehrlich M; Blobe GC; Henis YI
Mol Biol Cell; 2021 Apr; 32(7):605-621. PubMed ID: 33566682
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta1 causes pulmonary microvascular endothelial cell apoptosis via ALK5.
Lu Q; Patel B; Harrington EO; Rounds S
Am J Physiol Lung Cell Mol Physiol; 2009 May; 296(5):L825-38. PubMed ID: 19270180
[TBL] [Abstract][Full Text] [Related]
17. Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II.
Guerrero-Esteo M; Sanchez-Elsner T; Letamendia A; Bernabeu C
J Biol Chem; 2002 Aug; 277(32):29197-209. PubMed ID: 12015308
[TBL] [Abstract][Full Text] [Related]
18. Binding of coronin 1B to TβRI negatively regulates the TGFβ1 signaling pathway.
Kim GY; Lim HJ; Park HY
Biochem Biophys Res Commun; 2017 Aug; 490(2):574-579. PubMed ID: 28625921
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of the transforming growth factor-beta signaling pathway, endoglin, and early growth response-1 in stable plaques.
Bot PT; Hoefer IE; Sluijter JP; van Vliet P; Smits AM; Lebrin F; Moll F; de Vries JP; Doevendans P; Piek JJ; Pasterkamp G; Goumans MJ
Stroke; 2009 Feb; 40(2):439-47. PubMed ID: 19074480
[TBL] [Abstract][Full Text] [Related]
20. Endoglin is expressed on human chondrocytes and forms a heteromeric complex with betaglycan in a ligand and type II TGFbeta receptor independent manner.
Parker WL; Goldring MB; Philip A
J Bone Miner Res; 2003 Feb; 18(2):289-302. PubMed ID: 12568406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
